High incidence of atrial fibrillation in patients treated with ibrutinib
Florian Baptiste(Hôpital Nord), Franck Thuny(Assistance Publique Hôpitaux de Marseille), Michaël Peyrol(Hôpital Nord), Franck Paganelli(Inserm), Stéphane Éderhy, Jérémie Barraud(Hôpital Nord), Jennifer Cautela(Hôpital Nord), Laure Farnault(Aix-Marseille Université), Marion Escudier(Hôpital Nord), Thérèse Aurran(Institut Paoli-Calmettes), Noémie Resseguier(Aix-Marseille Université), Charles Dolladille(Inserm), Joachim Alexandre(Government of the United States of America), Ariel Cohen(3D Biomatrix (United States)), Yan Ancedy(Sorbonne Université), Chloé Ammar(Hôpital Nord), Mélanie Gaubert(Inserm)
Cited by 72
Related Papers
2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)
|European Heart Journal|2022|2.7k
2023 ESC Guidelines for the management of endocarditis
|European Heart Journal|2023|1.6k
Management of immune checkpoint blockade dysimmune toxicities: a collaborative position paper
|Annals of Oncology|2015|897